(2E)-3-(4-bromophenyl)-1-phenylprop-2-en-1-one, 95.0%, 10g

4-(3-CHLORO-PROPYL)-4-CYANO-PIPERIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER, 90.0%, 250mg

HPLC column NUCLEODUR® 100-5 C8 ec, 250 mm, 4 mm, 1 Piece(s)

(S)-3-([1,1'-Biphenyl]-4-yl)-2-aminopropanoic acid, 95.0%, 1g

2,4-Bis(4-methylpiperazin-1-yl)aniline, 97%, 250mg

Propyl 4-(2-chloropropanoylamino)benzoate, 98%, 2g

3-PHENYL-2,5-DIHYDRO-1H-PYRROLE HCL, 95.0%, 250mg

2-{[6-(3,5-dimethyl-1H-pyrazol-1-yl)-1,2,4,5-tetrazin-3-yl]amino}-2-(hydroxymethyl)propane-1,3-diol, 100mg

7-(Diethylamino)-2-oxochromene-3-carbonitrile, 97%, 1g

4-Bromo-2,6-difluoroaniline, 98.0%, 1kg

2-Bromo-5-methoxypyridine, 98.0%, 1g

2-(4-(Benzo[d][1,3]dioxol-5-ylmethyl)piperazin-1-yl)pyrimidine, 95.0%, 1g

Ethyl 5-amino-4-chloro-2-nitrobenzoate, 95%, 1g